These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1387880)

  • 1. Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns.
    Abdel Gadir A; Khatim MS; Mowafi RS; Alnaser HM; Muharib NS; Shaw RW
    Hum Reprod; 1992 Apr; 7(4):458-61. PubMed ID: 1387880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles.
    Abdel Gadir A; Khatim MS; Mowafi RS; Alnaser HM; Muharib NS; Shaw RW
    Hum Reprod; 1992 Apr; 7(4):453-7. PubMed ID: 1522185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
    Benjamin F; Deutsch S; Saperstein H; Seltzer VL
    Fertil Steril; 1986 Aug; 46(2):215-21. PubMed ID: 3015693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study.
    Gülekli B; Turhan NO; Senöz S; Kükner S; Oral H; Gökmen O
    Gynecol Endocrinol; 1993 Dec; 7(4):273-7. PubMed ID: 8147237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.
    Chang RJ; Mandel FP; Wolfsen AR; Judd HL
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1265-7. PubMed ID: 6281296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.
    Fox R; Corrigan E; Thomas PG; Hull MG
    Br J Obstet Gynaecol; 1991 Mar; 98(3):294-9. PubMed ID: 1827032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polycystic ovaries: specific disease picture or nonspecific symptom?].
    Moltz L; Sörensen R; Römmler A; Schwartz U; Hammerstein J
    Geburtshilfe Frauenheilkd; 1985 Feb; 45(2):107-14. PubMed ID: 3920114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.
    Carmina E; Rosato F; Maggiore M; Gagliano AM; Indovina D; Jannì A
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):99-104. PubMed ID: 6229966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian ultrasound and ovarian and adrenal hormones before and after treatment for hyperthyroidism.
    Skjöldebrand Sparre L; Kollind M; Carlström K
    Gynecol Obstet Invest; 2002; 54(1):50-5. PubMed ID: 12297719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinological and clinical analysis of hyperprolactinemic patients with and without ultrasonically diagnosed polycystic ovarian changes.
    Işik AZ; Gülekli B; Zorlu CG; Ergin T; Gökmen O
    Gynecol Obstet Invest; 1997; 43(3):183-5. PubMed ID: 9127132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
    Lobo RA; Kletzky OA; Campeau JD; diZerega GS
    Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.